Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Feb 2023
Historique:
pubmed: 23 6 2022
medline: 18 2 2023
entrez: 22 6 2022
Statut: ppublish

Résumé

Angioimmunoblastic T-cell lymphoma (AITL) is an intractable type of T-cell lymphoma. We and others have identified that the p.Gly17Val RHOA mutation is specifically identified in AITL. We herein report a patient whose condition deteriorated, resulting from massive pericardial effusion one month after undergoing autologous transplantation for AITL. He was diagnosed with cardiac tamponade caused by AITL recurrence in the presence of the p.Gly17Val RHOA mutation as well as T-lineage cells with an aberrant immune-phenotype in the pericardial effusion. This case suggests that a precision medicine approach by detecting the presence of a p.Gly17Val RHOA mutation is useful for the management of AITL.

Identifiants

pubmed: 35732446
doi: 10.2169/internalmedicine.9248-22
pmc: PMC10017241
doi:

Substances chimiques

RHOA protein, human 124671-05-2
rhoA GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-600

Références

Haematologica. 2017 Apr;102(4):e148-e151
pubmed: 28082343
Blood. 2012 Mar 22;119(12):2837-43
pubmed: 22308294
Ann Hematol. 2017 Sep;96(9):1471-1475
pubmed: 28634614
Br J Haematol. 2010 Mar;148(5):673-89
pubmed: 19961485
Nat Genet. 2014 Feb;46(2):166-70
pubmed: 24413734
Sci Transl Med. 2016 Nov 9;8(364):364ra155
pubmed: 27831904
Nat Genet. 2014 Feb;46(2):171-5
pubmed: 24413737
Blood. 2012 Feb 23;119(8):1901-3
pubmed: 22215888
Leukemia. 2016 May;30(5):1062-70
pubmed: 26719098
Blood. 2012 Aug 16;120(7):1466-9
pubmed: 22760778
Eur Heart J. 2014 Sep 7;35(34):2279-84
pubmed: 25002749
Pathol Int. 2020 Sep;70(9):653-660
pubmed: 32648273
Leukemia. 2020 Oct;34(10):2592-2606
pubmed: 32704161
Nat Genet. 2009 Jul;41(7):838-42
pubmed: 19483684
Blood. 2016 Sep 15;128(11):1490-502
pubmed: 27369867
Leukemia. 2018 Mar;32(3):694-702
pubmed: 28832024
Haematologica. 2018 Jun;103(6):e241-e244
pubmed: 29472348
Nat Genet. 2014 Apr;46(4):371-5
pubmed: 24584070
J Clin Oncol. 2008 Sep 1;26(25):4124-30
pubmed: 18626005
N Engl J Med. 2012 Jan 5;366(1):95-6
pubmed: 22216861
Blood. 2008 May 1;111(9):4463-70
pubmed: 18292286

Auteurs

Yuri Tsuboi (Y)

Department of Hematology, University of Tsukuba Hospital, Japan.

Yumoe Iimura (Y)

Department of Hematology, University of Tsukuba Hospital, Japan.

Fumiaki Matsumura (F)

Department of Hematology, University of Tsukuba Hospital, Japan.

Toru Nanmoku (T)

Department of Clinical Laboratory, University of Tsukuba Hospital, Japan.

Sakurako Suma (S)

Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.

Ryota Matsuoka (R)

Department of Pathology, Faculty of Medicine, University of Tsukuba, Japan.

Tomoki Nakagawa (T)

Department of Pathology, Faculty of Medicine, University of Tsukuba, Japan.

Daishi Nakagawa (D)

Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan.

Yasuhito Suehara (Y)

Department of Hematology, University of Tsukuba Hospital, Japan.

Keiichiro Hattori (K)

Department of Hematology, University of Tsukuba Hospital, Japan.

Kimi Sato (K)

Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan.

Yumiko Maruyama (Y)

Department of Hematology, University of Tsukuba Hospital, Japan.

Tatsuhiro Sakamoto (T)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Yasuhisa Yokoyama (Y)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Takayasu Kato (T)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Naoki Kurita (N)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Hidekazu Nishikii (H)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Naoshi Obara (N)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Masaki Ieda (M)

Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan.

Shigeru Chiba (S)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

Mamiko Sakata-Yanagimoto (M)

Department of Hematology, University of Tsukuba Hospital, Japan.
Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.
Division of Advanced Hemato-Oncology, Transborder Medical Research Center, University of Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH